Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
Tuesday, September 18, 2018Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation for North American rights to Samumeds SM being developed for the treatment of idiopathic pulmonary fibrosis IPF Deal terms include million upfront plus up to...
CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes
Tuesday, September 18, 2018CRISPR Therapeutics a biopharmaceutical company focused on developing transformative genebased medicines for serious diseases and ViaCyte Inc a privately held regenerative medicine company today announced a collaboration focused on the discovery deve...
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin®) In Canada
Monday, September 17, 2018Halozyme Therapeutics Inc today announced that Roche has received approval from Health Canada for a subcutaneous SC formulation of trastuzumab Herceptin SC for the treatment of patients with HERpositive breast cancer This is a coformulation with Halo...
BioArctic SIgns a Research Agreement With Brain Biomarker Solutions in Gothenburg AB to Develop New Diagnostics for Alzheimer's Disease
Saturday, September 15, 2018BioArctic AB has signed a research agreement with Brain Biomarker Solutions in Gothenburg AB BBS BBS was founded by the internationally wellknown researchers in the area of Alzheimer diagnostics Professors Kaj Blennow and Henrik Zetterberg and Univer...
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Saturday, September 15, 2018Allergan plc a leading global pharmaceutical company today announced it has agreed to acquire Bonti Inc a privately held clinicalstage biotechnology company focused on the development and commercialization of novel fastacting neurotoxin programs for...
Paragon BioTeck Reformulated FRESHKOTE®, Prompting Eyevance Acquisition
Friday, September 14, 2018Paragon BioTeck a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals devices and therapies recently completed the reformulation for the FRESHKOTE family of lubr...
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
Friday, September 14, 2018Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics a biopharmaceutical company specializing in the development of oncolytic viral therapies ViraTherapeutics developed the lead candidate VSVGP Vesicular Stomatitis...
Eyevance Pharmaceuticals Acquires FRESHKOTE® Lubricant Eye Drop Family of Products from Focus Laboratories
Wednesday, September 12, 2018Eyevance Pharmaceuticals LLC a Fort Worthbased pharmaceutical company committed to developing and commercializing innovative and impactful ophthalmic products today announced the acquisition of FRESHKOTE a family of lubricant eye drops from Focus La...
Casma Therapeutics Announces Partnership with Fondazione Telethon, Founder of the Telethon Institute of Genetics and Medicine (TIGEM)
Wednesday, September 12, 2018Casma Therapeutics Inc a biotechnology company harnessing the process of autophagy to design powerful new medicines today announced a research collaboration with Fondazione Telethon founder of the Telethon Institute of Genetics and Medicine TIGEM to...
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing
Tuesday, September 11, 2018WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing and Inhibrx Inc Inhibrx a biopharmaceutical company developing a diverse pipeline of no...
